Rhythm Biosciences Activates First Commercial Blood Collection Network for Cancer Blood Test Product; Shares Up 3%

MT Newswires Live

Mar 18

Rhythm Biosciences (ASX:RHY) said it successfully activated its first commercial blood collection network of clinics across major cities, enabling the scaling of cancer blood test, ColoSTAT's commercial testing services, according to a Wednesday Australian bourse filing.

The ColoSTAT test is a blood-based test for the detection of colorectal cancer.

4Cyte Pathology activated an initial network of 38 blood collection sites across major cities in Queensland, New South Wales, and Victoria, enabling clinician referral and patient access to ColoSTAT testing through an established clinician pathway, the filing added.

Clinicians within designated 4Cyte Pathology clinics are being onboarded to provide referrals for ColoSTAT testing, with additional collection sites planned as part of the ongoing commercial rollout, the filing added.

The company said immediate scale-up can now proceed directly with physicians and through the ColoSTAT access program using a validated commercial and logistical pathway.

The company's shares rose past 3% in recent Wednesday trade.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/news/2620077024"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2620077024\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2620077024?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-18 09:23","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2620077024","market":"us","top_or_hot":-1,"title":"Rhythm Biosciences Activates First Commercial Blood Collection Network for Cancer Blood Test Product; Shares Up 3%","media":"MT Newswires Live","content":"<html><body><p> <a href=\"https://laohu8.com/S/RHYN.AU\">Rhythm Biosciences</a> (ASX:RHY) said it successfully activated its first commercial blood collection network of clinics across major cities, enabling the scaling of cancer blood test, ColoSTAT's commercial testing services, according to a Wednesday Australian bourse filing.</p><p>The ColoSTAT test is a blood-based test for the detection of colorectal cancer.</p><p>4Cyte Pathology activated an initial network of 38 blood collection sites across major cities in Queensland, New South Wales, and <a href=\"https://laohu8.com/S/VCCTF\">Victoria</a>, enabling clinician referral and patient access to ColoSTAT testing through an established clinician pathway, the filing added.</p><p>Clinicians within designated 4Cyte Pathology clinics are being onboarded to provide referrals for ColoSTAT testing, with additional collection sites planned as part of the ongoing commercial rollout, the filing added.</p><p>The company said immediate scale-up can now proceed directly with physicians and through the ColoSTAT access program using a validated commercial and logistical pathway.</p><p>The company's shares rose past 3% in recent Wednesday trade.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Rhythm Biosciences Activates First Commercial Blood Collection Network for Cancer Blood Test Product; Shares Up 3%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRhythm Biosciences Activates First Commercial Blood Collection Network for Cancer Blood Test Product; Shares Up 3%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-03-18 09:23</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> <a href=\"https://laohu8.com/S/RHYN.AU\">Rhythm Biosciences</a> (ASX:RHY) said it successfully activated its first commercial blood collection network of clinics across major cities, enabling the scaling of cancer blood test, ColoSTAT's commercial testing services, according to a Wednesday Australian bourse filing.</p><p>The ColoSTAT test is a blood-based test for the detection of colorectal cancer.</p><p>4Cyte Pathology activated an initial network of 38 blood collection sites across major cities in Queensland, New South Wales, and <a href=\"https://laohu8.com/S/VCCTF\">Victoria</a>, enabling clinician referral and patient access to ColoSTAT testing through an established clinician pathway, the filing added.</p><p>Clinicians within designated 4Cyte Pathology clinics are being onboarded to provide referrals for ColoSTAT testing, with additional collection sites planned as part of the ongoing commercial rollout, the filing added.</p><p>The company said immediate scale-up can now proceed directly with physicians and through the ColoSTAT access program using a validated commercial and logistical pathway.</p><p>The company's shares rose past 3% in recent Wednesday trade.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"RHY.AU","symbol_name":"RHYTHM BIOSCIENCES LTD","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2620077024","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2620077024","pubTimestamp":1773796980,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Rhythm Biosciences  said it successfully activated its first commercial blood collection network of clinics across major cities, enabling the scaling of cancer blood test, ColoSTAT's commercial testing services, according to a Wednesday Australian bourse filing.The ColoSTAT test is a blood-based test for the detection of colorectal cancer.4Cyte Pathology activated an initial network of 38 blood collection sites across major cities in Queensland, New South Wales, and Victoria, enabling clinician referral and patient access to ColoSTAT testing through an established clinician pathway, the filing added.Clinicians within designated 4Cyte Pathology clinics are being onboarded to provide referrals for ColoSTAT testing, with additional collection sites planned as part of the ongoing commercial rollout, the filing added.The company said immediate scale-up can now proceed directly with physicians and through the ColoSTAT access program using a validated commercial and logistical pathway.The com","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"RHY.AU":"RHYTHM BIOSCIENCES LTD","BK7124":"保健护理服务"},"translate_title":"Rhythm Biosciences启动癌症血液检测产品首个商业血液采集网络；股价上涨3%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"RHY.AU":1},"content_text":"Rhythm Biosciences (ASX:RHY) said it successfully activated its first commercial blood collection network of clinics across major cities, enabling the scaling of cancer blood test, ColoSTAT's commercial testing services, according to a Wednesday Australian bourse filing.The ColoSTAT test is a blood-based test for the detection of colorectal cancer.4Cyte Pathology activated an initial network of 38 blood collection sites across major cities in Queensland, New South Wales, and Victoria, enabling clinician referral and patient access to ColoSTAT testing through an established clinician pathway, the filing added.Clinicians within designated 4Cyte Pathology clinics are being onboarded to provide referrals for ColoSTAT testing, with additional collection sites planned as part of the ongoing commercial rollout, the filing added.The company said immediate scale-up can now proceed directly with physicians and through the ColoSTAT access program using a validated commercial and logistical pathway.The company's shares rose past 3% in recent Wednesday trade.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}